Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T12:50:39.340Z.
Calculation as of: 2026-10-06T12:50:39.340Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2e8745362276acfcd64f5b9abcba69827836693d7b304a16c872192b0535814a
PE RATIO
N/A
Bicara Therapeutics Inc. Common Stock
Market Cap
$1.14B
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.12B
PE Ratio
15.01
TTM Avg
11.54
3Y Avg
13.50
5Y Avg
19.40
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc. Common Stock (BCAX) | $1.14B | N/A | N/A | N/A | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.14B | N/A | 47.35 | 23.64 | 23.64 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.12B | N/A | 100.60 | 100.60 | 255.09 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 15.01 | 11.54 | 13.50 | 19.40 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 79.06 | 42.78 | 72.87 | 84.11 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | N/A | N/A | N/A | N/A |
| Cronos Group Inc. (CRON)vs › | $1.21B | 17.95 | 29.62 | 28.16 | 28.16 |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | N/A | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.22B | N/A | 92.39 | 92.39 | 92.39 |
| Immatics N.V. (IMTX)vs › | $1.04B | N/A | 31.31 | 24.04 | 24.04 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$17.29
Forward EPS (Est.)
$-3.42
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
